<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and its <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> from 72 patients and 14 control samples were studied </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of adhesive molecules - E-cadherin and beta-catenin, antiadhesive molecule - tenascin C and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> suppressor KAI-1 (CD82) were studied by immunohistochemistry </plain></SENT>
<SENT sid="2" pm="."><plain>The expression of E-cadherin and beta-catenin, tenascin C and KAI-1 was significantly different in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and control samples </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of E-cadherin, tenascin C and KAI-1 was diverse in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> compared to <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The analysis of current data showed the association of E-cadherin expression with stage of disease and depth of invasion, such as the correlation of beta-catenin nuclear expression and tenascin C expression with depth of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> invasion </plain></SENT>
<SENT sid="5" pm="."><plain>These data may be a useful indicator of disease progression </plain></SENT>
</text></document>